Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
PPMS: Predictors of Disease Progression Still Unknown
Papers: 2 Apr 2012 - 9 Apr 2012
IL-1β Levels During MS Remission May Predict Progression
Comparative Effectiveness Research on the Treatment of Multiple Sclerosis: Request for Information from the Patient-Centered Outcomes Research Institute
Atacicept Phase 2 Trial Yields Disappointing Results for MS
MS Trial Alert: Researchers Nationwide Recruiting Children and Adolescents with MS for a Global Study of Gilenya
Papers: 30 Jan 2015 - 6 Feb 2015
Keystone Symposia Conference: Neuroinflammation in Diseases of the Central Nervous System
Split Personality
Multiple sclerosis from the standpoint of geographic distribution and race
Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables.
MS Research Australia
MS Patient, Ph.D.: Home From the Hospital
Gender Bender
MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials.
ECTRIMS Multiple Sclerosis Clinical Training Fellowship Programme
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Gray matter atrophy is related to long-term disability in multiple sclerosis.
Grant for Multiple Sclerosis Innovation (GMSI) 2016
Oral Contraceptive Use Linked to Less Severe Relapsing-Remitting MS
Papers: 15 Nov 2013 - 22 Nov 2013
Natalizumab Emerges on Top in Network Meta-Analysis
MS Research Roundup: February 20, 2014
Papers: 11 Oct 2013 - 18 Oct 2013
Lectures on the diseases of the nervous system.
Pages
« first
‹ previous
…
13
14
15
16
17
18
19
20
21
…
next ›
last »
